Eli Lilly lifts revenue outlook as weight-loss shot demand soars, shares jump - Reuters
The Quick Take
Eli Lilly lifts revenue outlook as weight-loss shot demand soars, shares jump Reuters Eli Lilly hikes sales outlook, as CEO says there's room for 'dramatic' obesity market expansion CNBC Eli Lilly Stock Jumps on Monster Earnings Powered by Mounjaro and Zepbound Barron's Eli Lilly Revenue Climbs on Demand for Obesity Drugs WSJ Earnings live updates: Eli Lilly stock pops as strong GLP-1 drug demand
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to Top stories - Google News.
Related
World
Canada unveils first national security strategy in more than 20 years
The strategy comes amid tension between Canada and its North American neighbor over tense trade negotiations.
World
'The city is alive': A brief peace in Kherson, but residents fear what comes next
A temporary ceasefire has brought rare quiet to Kherson, offering its residents a glimpse of normal life before fighting resumes.
World
Michigan Red Baron worker targeted in viral prank by influencer, receives over $280,000 in GoFundMe donations as internet rallies behind him
World
Healey backs away from cutting welfare cost despite warnings of public finance shortfall
Experts round on chancellor over ‘scattergun’ budget, saying he ducked big tax and spending decisions John Healey has backed away from cutting the cost of…